Causes of Inflammatory Atelectasis
Inflammatory atelectasis is primarily caused by inflammatory processes that lead to airway obstruction, increased surface tension in alveoli, and compression of lung parenchyma due to inflammatory exudates.
Primary Inflammatory Causes
Systemic Autoimmune Diseases
- Connective Tissue Disorders
- Systemic Lupus Erythematosus (SLE) - can cause plate-like atelectasis 1
- Rheumatoid Arthritis - associated with bronchiolitis and interstitial lung disease leading to atelectasis 1
- Sjögren's Syndrome - causes xerotrachea (dryness of the trachea) leading to discoid atelectasis 1
- Scleroderma - can cause interstitial lung disease with subsequent atelectasis 1
Inflammatory Airway Processes
- Infectious Causes
- Mycoplasma pneumoniae - can cause bronchial wall inflammation and edema leading to obstruction and atelectasis 2
- Bacterial pneumonia - inflammatory exudates can obstruct airways
- Viral respiratory infections - cause mucosal inflammation and increased secretions
Post-Injury Inflammatory Syndromes
- Post-Cardiac Injury Syndromes (PCIS)
- Post-pericardiotomy syndrome
- Post-traumatic pericarditis
- These have immune-mediated pathogenesis triggered by damage to pericardial/pleural tissues 1
Pathophysiological Mechanisms
Inflammatory Mediator-Driven Mechanisms
Cytokine-Mediated Inflammation
Cellular Mechanisms
- Neutrophil infiltration and enzyme release
- Macrophage activation and inflammatory mediator production
- Reactive oxygen species generation and lipid peroxidation 1
Specific Mechanisms Leading to Atelectasis
Airway Obstruction (Resorption Atelectasis)
- Inflammatory edema of bronchial walls
- Excessive mucus production and plugging
- Bronchospasm secondary to inflammation
- Cellular debris accumulation in airways 3
Surfactant Dysfunction (Adhesive Atelectasis)
- Inflammatory mediators inactivate surfactant
- Decreased surfactant production by damaged type II pneumocytes
- Increased surface tension causing alveolar collapse 3
Compressive Mechanisms
- Pleural effusions secondary to inflammation
- Inflammatory exudates in interstitial spaces
- Fibrotic changes in chronic inflammation 4
Clinical Presentations of Inflammatory Atelectasis
Acute Inflammatory Atelectasis
- Sudden onset with respiratory distress
- Often associated with acute infections or inflammatory conditions
- May present with fever, cough, and pleuritic chest pain
Chronic Inflammatory Atelectasis
- Gradual onset with progressive dyspnea
- Associated with chronic inflammatory conditions
- May present with recurrent infections and progressive respiratory insufficiency
Radiographic Patterns
Direct Signs of Atelectasis
- Crowded pulmonary vessels
- Crowded air bronchograms
- Displacement of interlobar fissures 4
Indirect Signs
- Pulmonary opacification
- Elevation of the diaphragm
- Shift of mediastinal structures
- Compensatory hyperexpansion of surrounding lung 4
Diagnostic Approach
Imaging Studies
Laboratory Evaluation
- Inflammatory markers (CRP, ESR)
- Autoimmune serologies when systemic autoimmune disease is suspected
- Microbiological studies when infection is suspected
Management Considerations
Treatment of Underlying Inflammation
- Target the specific inflammatory process causing atelectasis
- For autoimmune diseases: immunosuppressive therapy directed at controlling the underlying disease 1
- For infectious causes: appropriate antimicrobial therapy
Atelectasis-Specific Management
Advanced Respiratory Support
- PEEP (10-15 cm H₂O) for intubated patients
- CPAP or non-invasive positive pressure ventilation
- Alveolar recruitment maneuvers 5
Monitoring and Complications
Monitoring
- Arterial blood gases to assess oxygenation
- Follow-up chest radiographs to document resolution 5
Potential Complications
- Secondary bacterial pneumonia
- Hypercapnic respiratory failure
- Progression to chronic inflammatory lung disease 5
Understanding the specific inflammatory mechanism causing atelectasis is crucial for appropriate management and prevention of long-term complications.